Tech giants Rush into the AI Health Market! Samsung Introduces AI Health Assistant to Compete Directly with Apple and Google
Nowadays, more and more technology companies are using chatbots to provide personalized health analysis for users, and Samsung has officially entered this arena.
Samsung Electronics has launched a new artificial intelligence (AI) assistant that can act as a virtual health caretaker. More and more tech companies are now using Siasun Robot&Automation to provide personalized health analysis for users, and Samsung has officially joined this race.
Samsung announced on Tuesday that the Samsung Health Assistant can extract data from users' Galaxy smartphones, smartwatches, or smart rings. The company also announced a series of other features that will be released on its health platform, focusing on health indicators such as heart rate.
The above updates will be released in the form of a beta version next month, and users will need to opt in. This move marks Samsung's official entry into the increasingly competitive AI health race: screenless fitness wristband maker Whoop Inc. has integrated AI coaching features into its platform, Google's new Fitbit Air also has similar features; leading smart wristband brand Ora Health Oy has launched similar services, and Apple is also developing a similar product.
Hon Pak, senior vice president of Samsung's digital health business, stated that Samsung's solution has a differentiated advantage because these health features can deeply integrate with a broader Samsung ecosystem. The new assistant is equipped with Samsung's personalized data engine, which can read information such as schedules and travel plans from devices to customize exclusive health recommendations based on this information.
Pak said, "Based on the data collected from various connected devices and user status information, we can ultimately provide more personalized interactive services that are more relevant to the user's current situation."
Like other fitness devices and tools, Samsung's new AI assistant will not diagnose diseases, provide medical advice, or create treatment plans. "Currently, we are implementing protective measures for these functions," Pak said.
Samsung is also partnering with medical institutions including the National Institutes of Health, the Centers for Disease Control and Prevention, and the Massachusetts Institute of Technology to reduce the risk of AI providing incorrect answers and ensure that answers are based on medical research. Pak also stated that these features are protected by privacy and security measures at the software, hardware, and chip levels.
Reports suggest that Samsung is also building a platform for patients to share data with doctors, which is expected to be launched by the end of 2026 at the earliest. Pak stated that these new health features and platforms are part of the company's "last mile" strategy - a strategy that not only enables early screening of health risks but also ensures that patients can more easily follow the treatment plans set by their doctors.
Samsung's vision for this platform is that after patients leave the doctor's office, doctors can continuously access data from their wearable devices to monitor changes in health indicators such as blood pressure over the long term, thereby better understanding the patient's health status between visits. The platform's technology is based on the startup company Xealth, which Samsung acquired in 2025. Xealth is dedicated to helping doctors and hospitals connect wearable device data.
Pak said, "Many patients often forget the health action recommendations given by doctors after their visit. We are developing related features to convert these medical instructions into personalized tasks that can be automatically pushed as reminders, truly implementing health interventions."
Related Articles

The biggest winner is not AI! Biotech has become the dark horse of US stock market IPOs, with an average return of 55%, far outperforming the overall market.

The curse of "good news is bad news" reappears! The Citigroup Economic Surprise Index breaks through 40, and the US stock market may face the law of "three weeks of decline, three months of recovery".

Midterm elections enter the heart of asset pricing! Arizona primaries kick off, Trump's "election integrity" agenda faces a key stress test.
The biggest winner is not AI! Biotech has become the dark horse of US stock market IPOs, with an average return of 55%, far outperforming the overall market.

The curse of "good news is bad news" reappears! The Citigroup Economic Surprise Index breaks through 40, and the US stock market may face the law of "three weeks of decline, three months of recovery".

Midterm elections enter the heart of asset pricing! Arizona primaries kick off, Trump's "election integrity" agenda faces a key stress test.

RECOMMEND





